Proposed Final Judgment in US antitrust case against Live Nation Entertainment requires the company to divest certain assets and comply with operational restrictions affecting ticket sales and venue management; final judgment pending court approval.
FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.
Centers for Medicare & Medicaid Services launches a matching program with the Department of Veterans Affairs to verify eligibility for insurance affordability programs under the Affordable Care Act.
HUD published regulatory waivers granted during the third quarter of 2025 (July 1–September 30) in compliance with the HUD Reform Act's quarterly Federal Register notice requirement.
FDA submitted a proposed information collection to OMB for Paperwork Reduction Act review regarding formal hearing administrative procedures and practices.
The FCC prohibits importation and marketing of communications equipment designated as covered products in 2024 or earlier due to national security risks.
Federal agencies submit information collection requests to OMB for review and public comment to assess burden on businesses and the public.
The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
EPA received pesticide product registration applications for new uses of currently registered active ingredients and solicits public comments on the April 2026 compilations.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
